At a Glance
| BPC-157 | TB-500 | |
|---|---|---|
| Class | Synthetic pentadecapeptide | Synthetic peptide fragment of Thymosin Beta-4 |
| Length | 15 amino acids | 43-amino-acid-class fragment |
| Molecular formula | C62H98N16O22 | C212H350N56O78S |
| Molecular weight | 1,419.53 g/mol | ~4,963 g/mol |
| CAS | 137525-51-0 | — |
| Primary research pathway | Growth-factor / nitric-oxide system signaling | G-actin sequestration / cytoskeletal dynamics |
| Common research models | Connective tissue, gastric mucosa | Cell migration, cytoskeletal remodeling |
Structural Differences
BPC-157 and TB-500 are commonly studied together in the connective-tissue research literature, but they are structurally distinct compounds with different chemical classes. BPC-157 is a 15-amino-acid pentadecapeptide derived from a gastric protein — small, acid-stable, and dominated by proline residues. TB-500 is a substantially larger 43-amino-acid-class fragment of Thymosin Beta-4 with a single cysteine residue and a high water-solubility profile. Researchers cannot assume the two are interchangeable in any assay; they belong to different chemical classes and engage different cellular machinery.
Research Pathway Differences
The published research literature characterizes the two compounds via different primary mechanisms. BPC-157 work focuses on growth-factor signaling (VEGF, FGF), nitric oxide system interactions, and gastric-mucosa stability research. TB-500 work focuses on actin-binding kinetics — the fragment binds monomeric G-actin via a specific motif and modulates G-actin / F-actin equilibrium, the central machinery of cellular motility and cytoskeletal remodeling. The two compounds therefore answer different research questions even when used in the same in-vitro model system.
Common Research Models
Both compounds appear in scratch-wound migration assays in fibroblast and endothelial monolayers, ELISA-based growth-factor quantification, and histological evaluation of tissue ultrastructure in ex-vivo preparations. Researchers selecting between them — or combining them — should consult target literature carefully; the published methodologies for combination studies define specific concentration ratios and assay-system parameters that are not interchangeable across research contexts.
When Researchers Select Each — or the Blend
Research designs vary. Some studies use BPC-157 alone to investigate growth-factor pathway questions; others use TB-500 alone for cytoskeletal dynamics work; many combine both to study connective-tissue research more broadly. Solira Lab supplies both single compounds and a pre-formulated BPC-157 + TB-500 blend for laboratory-research convenience in dual-compound protocols.
Or view the pre-formulated BPC-157 + TB-500 Blend →
Related Research Compounds
- BPC-157 research reference — structural and methodological detail
- TB-500 research reference — structural and methodological detail
- GHK-Cu — copper tripeptide, the third component of the GLOW Stack blend
